Ordinary Rebalance | Several Solactive Indices | Effective Date 7th December 2023
Enhanced Consciousness Index:
In the ordinary rebalance, the following composition will be implemented effective open 07.12.2023:
| ACADIA PHARMACEUTICALS INC |
| ALKERMES PLC |
| ATAI LIFE SCIENCES B.V |
| BIOGEN INC |
| CEREVEL THERAPEUTICS HOLDINGS INC |
| COMPASS PATHWAYS PLC |
| DENALI THERAPEUTICS INC |
| GH RESEARCH PLC |
| H LUNDBECK AS – Class B |
| INTRA-CELLULAR THERAPIES INC |
| JAZZ PHARMACEUTICALS PLC |
| JOHNSON & JOHNSON |
| KARUNA THERAPEUTICS INC |
| MIND MEDICINE MINDMED INC |
| MURAL ONCOLOGY PLC |
| MYRIAD GENETICS INC |
| NEUROCRINE BIOSCIENCES INC |
| NRX PHARMACEUTICALS INC |
| PTC THERAPEUTICS INC |
| RELMADA THERAPEUTICS INC. |
| SAGE THERAPEUTICS INC |
| SAREPTA THERAPEUTICS INC |
| SEELOS THERAPEUTICS INC |
| TONIX PHARMACEUTICALS HOLDIN |
| UCB SA |
| VISTAGEN THERAPEUTICS INC |
Enhanced Consciousness Index:
In the ordinary rebalance, the following composition will be implemented effective open 07.12.2023:
| ACADIA PHARMACEUTICALS INC |
| ALKERMES PLC |
| ATAI LIFE SCIENCES B.V |
| BIOGEN INC |
| CEREVEL THERAPEUTICS HOLDINGS INC |
| COMPASS PATHWAYS PLC |
| DENALI THERAPEUTICS INC |
| GH RESEARCH PLC |
| H LUNDBECK AS – Class B |
| INTRA-CELLULAR THERAPIES INC |
| JAZZ PHARMACEUTICALS PLC |
| JOHNSON & JOHNSON |
| KARUNA THERAPEUTICS INC |
| MIND MEDICINE MINDMED INC |
| MURAL ONCOLOGY PLC |
| MYRIAD GENETICS INC |
| NEUROCRINE BIOSCIENCES INC |
| NRX PHARMACEUTICALS INC |
| PTC THERAPEUTICS INC |
| RELMADA THERAPEUTICS INC. |
| SAGE THERAPEUTICS INC |
| SAREPTA THERAPEUTICS INC |
| SEELOS THERAPEUTICS INC |
| TONIX PHARMACEUTICALS HOLDIN |
| UCB SA |
| VISTAGEN THERAPEUTICS INC |